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Previewsdistributions do not cease to surprise the
scientific community, and it is plausible
that more cell types and functions are
soon to be joining the club.
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In the present issue of Immunity, Hoeffel et al. (2015) reconcile a controversy by demonstrating that a distinct
wave of yolk-sac-derived erythro-myeloid progenitors (EMPs) differentiate to fetal monocytes in the liver and
further to adult macrophages in the majority of tissues.Macrophages are evolutionarily ancient
innate immune cells that are found in
most tissues and organs and whose func-
tions are highly specialized to their spe-
cific environments. It has been generally
accepted that the majority of tissue-
resident macrophage subsets originate
during fetal hematopoiesis and are there-
after maintained by local self-renewal with
minimal contribution of bone marrow
(BM)-derived progenitors. However, the
hemogenic site of origin within the em-
bryo has remained a matter of intense
debate, with controversial experimental
evidence supporting both fetal liver-
derived and yolk-sac (YS)-derived pro-
genitors. In this issue of Immunity, Hoeffel
et al. (2015) show that the majority of he-
matopoietic stem cell (HSC)-independent
tissue-resident macrophages originate
from fetal monocytes, which arise from
a transient wave of YS-derived erythro-
myeloid progenitors (EMPs) that colonize
the fetal liver.For the past 4 decades, it has been
widely accepted that blood monocytes
derived from BM hematopoietic stem
cells (HSCs) differentiate to macrophages
upon tissue entry. However, over the past
4 years, a torrent of reports has over-
turned this dogma. These reports have
unequivocally demonstrated an embry-
onic origin for the vast majority of tissue-
resident macrophages, which thereafter
are maintained largely independently of
adult HSC-dependent hematopoiesis.
Exceptions include intestinal and dermal
macrophages that are mainly BM mono-
cyte derived (Ginhoux and Jung, 2014).
Fetal hematopoiesis occurs in distinct
‘‘waves,’’ but their differential contribu-
tions to embryonic and adult macrophage
populations and the identity of precursors
has remained poorly characterized. In
the last trimester before the emergence
of mature tissue macrophages, fetal
organs contain two potential myeloid
progenitor populations, F4/80hiCD11bloprimitive macrophages and F4/80int
CD11bhi fetal monocytes, which are pro-
posed to arise from the YS and fetal liver,
respectively (Schulz et al., 2012). Opin-
ions differ on the question of which of the
two are the precursors of the mature tis-
sue resident macrophages. Using fate-
mapping, recent reports conclude that
tissue macrophages are predominantly
of fetal monocyte origin (Epelman et al.,
2014; Hoeffel et al., 2012), with the excep-
tion of microglia that derive from early
brain-seeding YS-derived primitive mac-
rophages (Ginhoux et al., 2010). Consis-
tently, adoptive cell transfer studies reveal
a bona fide alveolar macrophage progen-
itor potential of fetal monocytes (Guilliams
et al., 2013; Schneider et al., 2014). How-
ever, Geissmann and colleagues have
provided a strong argument that tissue
macrophages are derived from primi-
tive YS-derived macrophages, based on
the presence of F4/80hiCD11blo macro-
phages in skin, spleen, pancreas, kidney,42, April 21, 2015 ª2015 Elsevier Inc. 597
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Figure 1. Subsequent Waves of Erythro-Myeloid Progenitors in the Yolk Sac with Distinct
Fates for Primitive Macrophage and Fetal Monocyte Development
Early EMPs arise from hemogenic endothelial cells in the yolk sac around E7.5 and give rise to primitive
yolk sac macrophages, which seed peripheral tissues upon initiation of the blood circulation. Late
EMPs emerge in a subsequent wave around E8.5 and migrate through the blood to the fetal liver where
they give rise to various lineages including fetal monocytes. From E13.5, fetal monocytes colonize the
majority of organs, expand, and differentiate locally into mature tissue-resident macrophages, apart
from the brain, where the emerging blood-brain barrier might limit cellular influx. Hence, microglia derive
entirely from early EMPs. With the onset of HSC-dependent hematopoiesis, additional monocytes are
generated that originate from Flt3+ progenitors and differentially contribute to tissue macrophage popu-
lations. While early EMP-derived primitive macrophages and developing monocyte-derived tissuemacro-
phages coexist inmost organs between E17.5 and birth and display similar surfacemarker expression, the
former are increasingly diluted by mature tissue-resident macrophages, which in many organs are there-
after maintained independent of adult BM-derived progenitors through local self-renewal.
Immunity
Previewsand lung in embryos lacking the transcrip-
tion factor c-Myb (Schulz et al., 2012),
which is essential for fetal liver definitive
hematopoiesis.
Using novel fate-reporter mice, Rode-
wald and colleagues recently reported
that tissue macrophages emerge from
YS-derived EMPs that seed and expand
in the fetal liver independently of HSC-
dependent hematopoiesis (Gomez Perdi-
guero et al., 2015). Although this study
seems to exclude the possibility of fetal
monocyte origin, it does not address the
possibility of EMP diversity with distinct
myeloid progenitor fates in the yolk sac.
In an elegant series of cell depletion and
fate-mapping experiments, the present
study by Hoeffel et al. confirms the EMP
origin of tissue-resident macrophages
proposed by Perdiguero et al. and signifi-
cantly extends these findings by providing
evidence for at least two consecutive and
transient waves of EMPs from the yolk sac
with distinct programs for macrophage
development. A first wave consists of598 Immunity 42, April 21, 2015 ª2015 Elsevprimitive F4/80hiCD11blo macrophages
that colonize the brain and other fetal
organs and is followed by a second
wave that enters the fetal liver to develop
into fetal monocytes, which then seed the
tissues, except the brain, and develop
further into mature tissue macrophages
around the time of birth (Figure 1).
In accordance with a previous report
(Schulz et al., 2012), the authors found
that until E13.5, most organs harbor a
distinct population of F4/80hiCD11blo
macrophages resembling the primitive
yolk sac equivalents, which develop inde-
pendently of c-Myb. From E13.5, each
organ analyzed, apart from the brain,
was seeded by F4/80intCD11bhi fetal
monocytes. With a single injection of
a blocking colony stimulating factor-1
receptor (CSF-1R) antibody at E6.5,
the authors successfully depleted F4/
80hiCD11blo primitive macrophages in
YS and peripheral tissues transiently be-
tween E10.5 and E14.5 while leaving fetal
monocytes intact. The absence of theier Inc.early primitive macrophages prevented
microglia development but did not affect
the emergence of other tissue macro-
phages at E17.5, indicating that these
cells originated from fetal monocytes.
They followed this experiment with an
elegant fate-mapping approach, allowing
the specific tagging of two sequentially
arising EMP types with distinct macro-
phage fates in the yolk sac. Labeling of
the early EMPs resulted in a comparably
high proportion of labeled macrophages
in each organ analyzed at E13.5, which
gradually declined thereafter and disap-
peared almost completely in liver, skin,
kidney, and lung shortly after birth. In
contrast, microglia maintained the same
degree of labeling into adulthood at a
level similar to YS macrophages, demon-
strating a fundamentally different origin of
microglia compared to resident macro-
phages in other tissues. Conversely,
labeling of the late EMP resulted in a
steady increase in the percentage of
labeled macrophages from E13.5 to birth
in the same organs except the brain.
In order to track fetal monocytes and
their progenies, the authors employed
S100a4-cre mice. Expression of the
S100a4 gene is much higher in fetal
monocytes compared to fetal and adult
macrophages. In support of their hypoth-
esis that fetal monocyte-derived tissue
macrophages replace primitive YS mac-
rophages, the authors observed a gradual
increase in labeling of tissue macro-
phages, whereas microglia and YS
macrophages exhibited comparably low
levels of reporter activity.
The authors next compared fetal liver
and adult BM monopoiesis using surface
markers together with computational ana-
lyses of gene-expression patterns, which
revealed multiple similarities between
development of fetal and adultmonocytes
involving Flt3+-macrophage-dendritic cell
precursors (MDPs) and common mono-
cyte progenitor (cMoP) intermediates.
Moreover, they identified a myeloid pro-
genitor (MP) that was present only in the
fetal liver. Utilization of Flt3-cre reporter
mice revealed that MPs develop indepen-
dently of Flt3+HSC-derived progenitors.
Whereas MPs and MDPs shared the ca-
pacity to differentiate into cMoPs and
monocytes in vitro, the authors found
only a modest contribution of Flt3+ pro-
genitors to the development of cMoPs
and fetal monocytes in vivo. In agreement
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Previewswith previous reports (Epelman et al.,
2014; Gomez Perdiguero et al., 2015;
Schulz et al., 2012), the authors found
that Flt3-labeled HSC-derived progenitor
cells had differential contributions to adult
tissue macrophages, with microglia being
completely Flt3-independent and dermal
and splenic macrophages, as well as
lung and epidermal macrophages, arising
partially from Flt3+ progenitors, which
likely include fetal monocytes derived
fromMDP. On the basis of these observa-
tions, the authors posit that the proportion
of tissue macrophages negative for Flt3-
Cre represent the progeny of fetal mono-
cytes arising from from late YS EMPs
through the MP intermediate. Whether
the fate of EMPs is further influenced by
intrinsic differences between early and
late EMPs requires further investigation.
However, altered expression of Myb and
a differentially activeCsf1r locus indicated
that a grade of heterogeneity between
early and late EMPs existed in the YS.
Moreover, the authors found that the
few early EMPs that reached the liver
preferentially gave rise to fetal macro-
phages, but not fetal monocytes or their
progenies, and were rapidly replaced by
later EMPs.
On the basis of these data, the authors
propose a model in which early arising
EMPs in theYS locally give rise to primitive
macrophages, which colonize tissues
upon initiation of the blood circulation
and appear as F4/80hiCD11blo primitive
fetal macrophages (Figure 1). Concomi-
tantly, later emerging EMPs migrate in
the blood to the fetal liver, where they
differentiate into fetal monocytes through
a cMoP intermediate, similar to monocyte
development in the BM (Ginhoux and
Jung, 2014), before they eventually seed
peripheral tissues to develop into mature
resident macrophages (Figure 1). Subse-
quently, HSC-derived Flt3+MDPspartiallycontribute to the pool of fetal monocytes
and, to varying degrees, to adult tissue
macrophages. Although it remains un-
clear how the contributions of these cell
types to different tissue macrophages is
regulated, spatio-temporal colonization
and signals from the microenvironment
that control engraftment and final differen-
tiation are likely involved. An exception to
the common fetal monocyte origin of tis-
sue macrophages are brain microglia,
which originate from early EMP-derived
YS macrophages, possibly due to the
emerging blood-brain barrier, which could
limit access of fetal monocytes to the
brain. Interestingly, increased frequencies
of monocytes and monocyte-derived
macrophages in the brain were observed
upon depletion of YS macrophages,
suggesting that they might also have
microglia precursor potential, although
their functional capacity remains elusive.
However, it is unclear if the reverse is
also true; that YS macrophages could
adopt tissue macrophage phenotypes
and functions in organs other than the
brain in the absence of monocyte
colonization. Moreover, the physiological
reason for the replacement of YS macro-
phages by fetalmonocytes inmost organs
is unclear. Whether YS macrophages
have limited proliferative capacity or
function and whether fetal monocytes
acquire essential properties for subse-
quent differentiation into tissue macro-
phages during their maturation in the fetal
liver will be the subject of interesting future
studies.
Previous studies identified fetal mono-
cytes as the main precursors for tissue-
resident macrophages with the exception
of microglia (Epelman et al., 2014; Gin-
houx and Jung, 2014; Guilliams et al.,
2013; Hoeffel et al., 2012; Schneider
et al., 2014). These studies have been
difficult to reconcile with a possibleImmunityMyb-independent YS origin for most tis-
sue macrophages (Schulz et al., 2012).
While the requirement and role of c-Myb
warrants further investigation, Hoeffel
et al. present a coherent model for the
development of tissue-resident macro-
phages, which potentially resolves a long-
standing controversy regarding YS versus
fetal liver origin of tissue macrophages
and unites the field on this important
developmental process.REFERENCES
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